Pharmavite Agrees To $1.9M Settlement In TripleFlex Class Action
This article was originally published in The Rose Sheet
Executive Summary
Pharmavite will pay $1.9m and discontinue joint improvement claims for four Nature Made TripleFlex glucosamine products under terms of a class-action settlement in a six-year dispute over the truthfulness of joint renewal and rejuvenation claims.